[
    [
        {
            "time": "2023-10-05",
            "original_text": "Eisai, Biogen start U.S. accelerated approval for new Alzheimer's drug",
            "features": {
                "keywords": [
                    "Eisai",
                    "Biogen",
                    "U.S.",
                    "accelerated approval",
                    "Alzheimer's drug"
                ],
                "sentiment_score": 0.75,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "Eisai, Biogen start U.S. accelerated approval for new Alzheimer's drug",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-10-06",
            "original_text": "New Data from Verzenio® (abemaciclib) monarchE Study to Be Featured in ESMO Virtual Plenary",
            "features": {
                "keywords": [
                    "Verzenio",
                    "abemaciclib",
                    "monarchE Study",
                    "ESMO",
                    "Virtual Plenary"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "biotech"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "New Data from Verzenio® (abemaciclib) monarchE Study to Be Featured in ESMO Virtual Plenary",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "2023-10-07",
            "original_text": "Medicine’s Golden Age Is Dawning. 10 Stocks to Play the Latest Innovations.",
            "features": {
                "keywords": [
                    "Golden Age",
                    "innovations",
                    "stocks"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare",
                    "technology"
                ],
                "causal_factor": "false",
                "causal_impact": "none",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Medicine’s Golden Age Is Dawning. 10 Stocks to Play the Latest Innovations.",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 5,
                "Impact": 4,
                "Duration": 3,
                "Entity_Density": 3,
                "Market_Scope": 7,
                "Time_Proximity": 5,
                "Headline_Structure": 9,
                "Source_Recency": 6
            }
        },
        {
            "time": "2023-10-08",
            "original_text": "Eli Lilly Recalls Batch Of Low Blood Sugar Med Due To Health Risk",
            "features": {
                "keywords": [
                    "Eli Lilly",
                    "Recalls",
                    "Batch",
                    "Low Blood Sugar Med",
                    "Health Risk"
                ],
                "sentiment_score": -0.6,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "Eli Lilly Recalls Batch Of Low Blood Sugar Med Due To Health Risk",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        }
    ]
]